Full Paper
5-(4-tert-Butylphenyl)-4-(thiophen-2-yl)-pyrimidine (4b): Yield 7.95–7.98 (m, 2 H, H-6 or H-7 and H-2 or H-3), 8.09 (d, J = 5.3 Hz, 1
1
78 %; beige solid; m.p. 126–128 °C. H NMR (500 MHz, CDCl3): δ = H, H-2 or H-3), 8.64 (s, 1 H, H-4), 8.85 (d, J = 8.7 Hz, 1 H, H-6 or H-
1.43 (s, 9 H, tBu), 6.86–6.90 (m, 2 H, thienyl), 7.30 (d, J = 8.1 Hz, 2 7), 9.46 (s, 1 H, H-8), 10.08 (s, 1 H, H-10) ppm. 13C NMR (126 MHz,
3
H, Ph), 7.42 (d, J = 4.6 Hz, 1 H, thienyl), 7.52 (d, J = 8.1 Hz, 2 H, Ph), CDCl3): δ = 96.11, 119.28, 121.89 (q, JC,F = 4.0 Hz, CF3), 122.89,
8.56 (s, 1 H, H-6), 9.12 (s, 1 H, H-2) ppm. 13C NMR (126 MHz, CDCl3): 123.08, 123.36 (q, 3JC,F = 3.7 Hz, CF3), 123.61, 125.06, 128.51, 129.21,
δ = 31.36, 34.78, 126.07, 128.03, 128.76, 130.19, 130.74, 130.97, 130.08, 130.34, 130.60, 132.01, 136.26, 140.62, 149.25, 154.51,
133.23, 141.98, 152.08, 156.34, 157.18, 158.39 ppm. GC: tR
=
157.06 ppm. 19F NMR (470.5 MHz, CDCl3): δ = 99.48 (s, CF3) ppm.
25.44 min. MS: m/z (%) = 294 (100) [M+]. C18H18N2S C: calcd. 73.43,
IR (DRA): ν = 489, 496, 573, 629, 655, 679, 688, 705, 742, 759, 801,
˜
H 6.16, N 9.51; found C 73.59, H 6.36, N 9.63.
831, 841, 911, 929, 994, 1014, 1081, 1117, 1154, 1183, 1268, 1288,
1302, 1328, 1342, 1385, 1401, 1427, 1446, 1456, 1488, 1519, 1554,
4-(Thiophen-2-yl)-5-(4-trifluoromethylphenyl)pyrimidine (4c):
Yield 95 %; pale-yellow solid; m.p. 125–127 °C. 1H NMR (500 MHz,
CDCl3): δ = 6.82 (dd, J = 3.8, 0.8 Hz, 1 H, H-3′), 6.92 (dd, J = 5.0,
3.8 Hz, 1 H, H-4′), 7.46 (dd, J = 5.0, 0.8 Hz, 1 H, H-5′), 7.54 (d, J =
1580, 1628, 1786, 1819, 1911, 3054, 3087, 3110 cm–1. GC: tR
=
25.09 min. MS: m/z (%) = 304 (100) [M+]. C15H7F3N2S (304.29): calcd.
C 59.21, H 2.32, N 9.21; found C 59.11, H 2.49, N 9.10.
8.1 Hz, 2 H, Ph), 7.78 (d, J = 8.1 Hz, 2 H, Ph), 8.55 (s, 1 H, H-6), 9.17
Synthesis of 5-Bromo-4,6-di(thiophen-2-yl)pyrimidine (7): Thi-
enyllithium was prepared by adding nBuLi (1.6 M in hexane,
27.25 mL, 43.6 mmol) to thiophene (4.3 mL, 54.5 mmol) in diethyl
ether (50 mL) at –10 °C. The reaction mixture was stirred at 0 °C for
4 h. This solution was maintained at –30 °C while a solution of 5-
1
(s, 1 H, H-2) ppm. 13C NMR (126 MHz, CDCl3): δ = 123.89 (d, JC,F
=
4
272.5 Hz), 126.18 (q, JC,F = 3.7 Hz), 128.19, 129.60, 129.71, 130.76,
2
130.86, 131.11 (q, JC,F = 32.7 Hz), 140.12, 141.26, 156.21, 157.88,
158.01 ppm. 19F NMR (470.5 MHz, CDCl3): δ = 99.10 (s, CF3) ppm.
GC: tR = 22.14 min. MS: m/z (%) = 306 (100) [M+]. C15H9F3N2S bromo-4-thiophen-2-yl-pyrimidine (2) (1.315 g, 5.45 mmol) was
(306.30): calcd. C 58.82, H 2.96, N 9.15; found C 58.71, H 2.90, N added slowly with stirring during 10 min. The resulting mixture was
9.09.
stirred for 18 h at room temperature, then the reaction was
quenched at 0 °C with stirring with a solution of K3Fe(CN)6 (3.589 g,
10.9 mmol) in water (100 mL). The resulting mixture was stirred for
6 h at room temperature, the precipitate formed was filtered off,
washed with H2O and air dried. The residue was purified by flash
column chromatography (hexane/ethyl acetate, 1:3) to afford 7,
yield (1.233 g, 70 %); yellow powder; m.p. 129–131 °C1. 1H NMR
(500 MHz, CDCl3): δ = 7.20 (dd, J = 5.1, 3.9 Hz, 2 H, H-4′), 7.62 (dd,
J = 5.1, 1.0 Hz, 2 H, H-5′), 8.37 (dd, J = 3.9, 1.0 Hz, 2 H, H-5′), 8.93
(s, 1 H, H-2) ppm. 13C NMR (126 MHz, CDCl3): δ = 112.00, 127.87,
General Procedure for the Syntheses of 7-Substituted
Benzo[f]thieno[3,2-h]quinazolines 5a–c: To a solution of 4a, 4b
or 4c (1 mmol) in MeCN (150 mL) was added iodine (0.037 g,
0.14 mmol). The reaction mixture was irradiated at room tempera-
ture using a UV lamp for an appropriate time (see Table 1, entries
1–3). The solvent was then distilled off in vacuo, and the residue
was dissolved in CHCl3, washed with aqueous Na2S2O3, water, and
brine, dried with anhydrous Na2SO4 and the solvents evaporated.
The residue was purified by flash column chromatography (EtOAc/
hexane, 1:3) to afford the desired benzo[f]thieno[3,2-h]quinazoline
systems.
131.37, 132.52, 141.51, 155.28, 159.15 ppm. IR (DRA): ν = 460, 577,
˜
616, 627, 644, 714, 747, 776, 839, 860, 913, 963, 975, 1024, 1043,
1055, 1066, 1086, 1107, 1161, 1198, 1225, 1266, 1304, 1317, 1348,
1364, 1375, 1423, 1450, 1476, 1520, 1536, 1649, 1746, 1820, 1917,
2172, 2322, 2389, 2475, 2628, 2847, 2926, 3035, 3088, 3103,
3127 cm–1. GC: tR = 26.88 min. MS: m/z (%) = 322 (100) [M+; 79Br],
324 (100) [M+; 81Br]. C12H7BrN2S2 (323.22): calcd. C 44.59, H 2.18, N
8.67; found C 44.40, H 2.35, N 8.44.
Benzo[f]thieno[3,2-h]quinazoline (5a): Yield 43 %; beige solid;
m.p. 199–201 °C. H NMR (500 MHz, CDCl3): δ = 7.66–7.79 (m, 2 H,
Ph), 7.86 (d, J = 5.3 Hz, 1 H, H-2 or H-3), 7.88 (d, J = 5.3 Hz, 1 H, H-
2 or H-3), 8.29–8.35 (m, 1 H, Ph), 8.63–8.38 (m, 1 H, Ph), 9.38 (s, 1
H, H-8), 9.99 (s, 1 H, H-10) ppm. 13C NMR (126 MHz, CDCl3): δ =
120.14, 122.67, 123.14, 124.58, 126.82, 127.33, 128.66, 128.87,
1
General Procedure for the Syntheses of 5-(4-R-phenyl)-4,6-
Di(thiophen-2-yl)pyrimidines 8a–c: A solution of K2CO3 (346 mg,
2.5 mmol) in H2O (3 mL) was added to a mixture of 5-bromo-4,6-
dithiophen-2-yl-pyrimidine (7) (162 mg, 0.5 mmol), phenylboronic
[4-tert-butylphenylboronic acid or 4-(trifluoromethyl)phenylboronic]
acid (0.6 mmol) and Pd(PPh3)4 (29 mg, 5 mol-%) in 1,4-dioxane
(4 mL). The resulting mixture was irradiated in a microwave appara-
tus at 170 °C (250 W) for 20 min. The solvent was then distilled off
in vacuo, and the residue was purified by flash column chromatog-
raphy (hexane/ethyl acetate, 1:3) to afford the desired cross-cou-
pling products 8a, 8b, and 8c.
131.30, 135.01, 141.26, 148.61, 153.98, 156.13 ppm. IR (DRA): ν =
˜
486, 579, 623, 637, 667, 704, 735, 768, 792, 804, 819, 897, 915, 941,
996, 1013, 1044, 1071, 1115, 1147, 1209, 1270, 1336, 1393, 1404,
1423, 1446, 1458, 1486, 1509, 1551, 1566, 1579, 1612, 1661, 1744,
2853, 2924, 3069, 3101 cm–1. GC: tR = 26.09 min. MS: m/z (%) = 236
(100) [M+]. C14H8N2S (236.29): calcd. C 71.16, H 3.41, N 11.86; found
C 71.26, H 3.21, N 11.79.
7-tert-Butylbenzo[f]thieno[3,2-h]quinazoline (5b): Yield 49 %;
pale-yellow solid; m.p. 174–176 °C. 1H NMR (500 MHz, CDCl3): δ =
1.50 (s, 9 H, tBu), 7.80 (d, J = 8.5 Hz, 1 H, H-6 or H-7), 7.87 (d, J =
5.2 Hz, 1 H, H-2 or H-3), 8.05 (d, J = 5.2 Hz, 1 H, H-2 or H-3), 8.32 (s,
1 H, H-4), 8.62 (d, J = 8.5 Hz, 1 H, H-6 or H-7), 9.36 (s, 1 H, H-8), 9.98
(s, 1 H, H-10) ppm. 13C NMR (126 MHz, CDCl3): δ = 31.34, 35.17,
120.15, 120.44, 122.51, 123.11, 124.49, 125.57, 128.81, 131.00,
5-Phenyl-4,6-di(thiophen-2-yl)pyrimidine (8a): Yield 87 %; off-
white solid; m.p. 216–218 °C. 1H NMR (500 MHz, CDCl3): δ = 6.48
(dd, J = 3.9, 0.7 Hz, 2 H, H-3′), 6.82 (dd, J = 5.0, 3.9 Hz, 2 H, H-4′),
7.35 (dd, J = 7.4, 1.9 Hz, 2 H, Ph), 7.37 (dd, J = 5.0, 0.7 Hz, 2 H, H-5′
), 7.57–7.62 (m, 3 H, Ph), 9.07 (s, 1 H, H-2) ppm. 13C NMR (126 MHz,
CDCl3): δ = 125.64, 127.99, 129.40, 129.90, 130.23, 130.40, 131.04,
134.94, 141.55, 148.39, 151.97, 153.82, 155.81 ppm. IR (DRA): ν =
˜
503, 576, 610, 629, 684, 728, 799, 828, 847, 890, 906, 942, 993, 1012,
1073, 1103, 1114, 1160, 1202, 1215, 1259, 1332, 1342, 1344, 1360,
1396, 1422, 1453, 1482, 1510, 1550, 1577, 1618, 1659, 1811, 2865,
2903, 2950, 3045, 3068 cm–1. GC: tR = 28.63 min. MS: m/z (%) = 292
(100) [M+]. C18H16N2S (292.40): calcd. C 73.94, H 5.52, N 9.58; found
C 73.80, H 5.36, N 9.47.
136.42, 142.71, 156.84, 157.69 ppm. IR (DRA): ν = 450, 503, 555, 569,
˜
590, 620, 637, 680, 708, 752, 775, 793, 811, 856, 923, 957, 970, 994,
1004, 1042, 1051, 1073, 1087, 1117, 1162, 1186, 1226, 1236, 1275,
1297, 1343, 1379, 1410, 1430, 1445, 1489, 1536, 1576, 1627, 1751,
1813, 1897, 1969, 2327, 3020, 3077, 3119 cm–1. GC: tR = 28.76 min.
MS: m/z (%) = 320 (100) [M+]. C18H12N2S2 (320.43): calcd. C 67.47, H
7-(Trifluoromethyl)benzo[f]thieno[3,2-h]quinazoline (5c): Yield
1
72 %; beige solid; m.p. 248–250 °C. H NMR (500 MHz, CDCl3): δ = 3.77, N 8.74; found C 67.69, H 3.67, N 8.59.
Eur. J. Org. Chem. 2016, 1420–1428
1426
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim